-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NZKgdSMJ8Ra21Bqm2TVL347SARXIpwuXZxE+Y3kGBPaBWiI4kIIDFIlN8XgxibZV vcCYtVosjt6JuhbrXSyKHQ== 0001104659-06-019973.txt : 20060328 0001104659-06-019973.hdr.sgml : 20060328 20060328210942 ACCESSION NUMBER: 0001104659-06-019973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060324 FILED AS OF DATE: 20060328 DATE AS OF CHANGE: 20060328 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABGENIX INC CENTRAL INDEX KEY: 0001052837 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943248826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5106086500 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolff Henry Ward CENTRAL INDEX KEY: 0001302390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24207 FILM NUMBER: 06716505 BUSINESS ADDRESS: BUSINESS PHONE: 510-608-6500 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 a4.xml 4 X0202 4 2006-03-24 0 0001052837 ABGENIX INC ABGX 0001302390 Wolff Henry Ward 6701 KAISER DRIVE FREMONT CA 94555 0 1 0 0 CFO & SVP, Finance Common Stock 2006-03-24 4 M 0 13900 8.98 A 16394 D Common Stock 2006-03-24 4 M 0 8600 10.91 A 24994 D Incentive Stock Option (right to buy) 8.98 2006-03-24 4 M 0 13900 0 D 2005-09-01 2012-01-19 Common stock 13900 31682 D Non-Qualified Stock Option (right to buy) 10.91 2006-03-24 4 M 0 8600 0 D 2005-09-13 2011-09-13 Common stock 8600 166400 D 8/48 OF THE TOTAL SHARES SUBJECT TO THE OPTIONS REPORTED ON THIS FORM BECAME EXERCISABLE ON SEPTEMBER 1, 2005 AND AN ADDITIONAL 1/48 OF THE TOTAL SHARES SUBJECT TO THE OPTIONS REPORTED ON THIS FORM SHALL BECOME EXERCISABLE ON EACH FULL MONTH THEREAFTER. 1/4 OF THE TOTAL SHARES SUBJECT TO THE OPTION BECAME EXERCISABLE ONE YEAR FROM THE HIRE DATE AND AN ADDITIONAL 1/48 OF THE TOTAL SHARES SUBJECT TO THE OPTION SHALL BECOME EXERCISABLE EACH FULL MONTH THEREAFTER. SECURITIES OWNED INCLUDE SHARES ACQUIRED UNDER THE ABGENIX, INC. EMPLOYEE STOCK PURCHASE PLAN. /s/ Henry Ward Wolff 2006-03-27 -----END PRIVACY-ENHANCED MESSAGE-----